↑ Grab this Headline Animator

Citra Anticoagulants Inc. and H.A.C. Pharma Sign Marketing Agreement...

Citra Anticoagulants, Inc. a leading, developer and worldwide distributor of citrate-based anticoagulants used in dialysis, reconstructive, and orthopaedic markets, reported today that is has signed an exclusive Marketing Services Agreement with H.A.C. Pharma for Loxxit Catheter Lock Solution.

The Agreement appoints H.A.C. Pharma as Citra's sole representative to promote the marketing and sales activities of LOXXIT Catheter Lock Solution, 46.7% Trisodium Citrate Dihydrate, to distributors in Europe, the Middle East, and Africa.

H.A.C. Pharma is headquartered in Caen, France. It is a pharmaceutical marketing company focused on specialty therapeutic areas. The company commercializes drugs, medical devices, and food supplements for medical purposes in France and throughout the world. For more information and how to contact H.A.C. Pharma, visit

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Citra | Catheter Lock | catheter lock solution |

---

4933 readers online...

, Local News